(KR) Kroger - Overview
Sector: Consumer DefensiveIndustry: Grocery Stores | Exchange NYSE (USA) | Currency USD | Market Cap: 44.079m | Total Return 10.4% in 12m
Stock: Groceries, Pharmacy, Fuel, Apparel, General Merchandise
Total Rating 56
Risk 77
Buy Signal 0.05
| Risk 5d forecast | |
|---|---|
| Volatility | 24.8% |
| Relative Tail Risk | -8.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.43 |
| Alpha | 10.92 |
| Character TTM | |
|---|---|
| Beta | -0.236 |
| Beta Downside | -0.078 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.44% |
| CAGR/Max DD | 0.86 |
EPS (Earnings per Share)
Revenue
Description: KR Kroger March 02, 2026
The Kroger Co. (NYSE: KR) is a U.S. food and drug retailer that runs a diversified portfolio of formats-including combination food-and-drug stores, multi-department stores, marketplace stores, and price-impact warehouses-along with its own food-manufacturing, fuel centers, and online sales channels.
In its most recent fiscal year (FY 2025), Kroger reported revenue of $136.2 billion, with comparable-store sales rising 3.1% year-over-year and digital sales now representing roughly 13% of total sales; its operating margin improved to 3.2% and its private-label share reached a record 31% of basket value.
Key drivers for the grocery sector remain consumer price sensitivity as inflation eases, a continued shift toward higher-margin private-label and organic products, and accelerated e-commerce adoption-areas where Kroger’s robust omnichannel platform and extensive fresh-food assortment give it a competitive edge.
For deeper quantitative analysis, you may want to explore ValueRay’s detailed model on KR.
Headlines to watch out for
- Grocery price inflation impacts consumer spending
- Labor costs and supply chain efficiency affect margins
- Online grocery sales growth drives market share
- Regulatory scrutiny on mergers and acquisitions
- Fuel price volatility influences consumer traffic
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.02b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.67 > 1.0 |
| NWC/Revenue: -2.42% < 20% (prev -0.45%; Δ -1.97% < -1%) |
| CFO/TA 0.15 > 3% & CFO 7.38b > Net Income 1.02b |
| Net Debt (21.35b) to EBITDA (5.47b): 3.90 < 3 |
| Current Ratio: 0.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (631.0m) vs 12m ago -9.34% < -2% |
| Gross Margin: 22.28% > 18% (prev 0.23%; Δ 2.21k% > 0.5%) |
| Asset Turnover: 287.9% > 50% (prev 279.6%; Δ 8.31% > 0%) |
| Interest Coverage Ratio: 2.59 > 6 (EBITDA TTM 5.47b / Interest Expense TTM 704.0m) |
Altman Z'' 1.62
| A: -0.07 (Total Current Assets 14.51b - Total Current Liabilities 18.09b) / Total Assets 49.94b |
| B: 0.56 (Retained Earnings 28.20b / Total Assets 49.94b) |
| C: 0.04 (EBIT TTM 1.82b / Avg Total Assets 51.28b) |
| D: 0.01 (Book Value of Equity 614.0m / Total Liabilities 44.01b) |
| Altman-Z'' Score: 1.62 = BB |
Beneish M -3.15
| DSRI: 1.00 (Receivables 2.19b/2.19b, Revenue 147.64b/147.12b) |
| GMI: 1.02 (GM 22.28% / 22.70%) |
| AQI: 0.99 (AQ_t 0.09 / AQ_t-1 0.09) |
| SGI: 1.00 (Revenue 147.64b / 147.12b) |
| TATA: -0.13 (NI 1.02b - CFO 7.38b) / TA 49.94b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of KR shares?
As of March 30, 2026, the stock is trading at USD 73.22 with a total of 5,922,749 shares traded.
Over the past week, the price has changed by +0.72%, over one month by +7.30%, over three months by +17.35% and over the past year by +10.38%.
Over the past week, the price has changed by +0.72%, over one month by +7.30%, over three months by +17.35% and over the past year by +10.38%.
Is KR a buy, sell or hold?
Kroger has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold KR.
- StrongBuy: 9
- Buy: 3
- Hold: 12
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74.9 | 2.3% |
| Analysts Target Price | 74.9 | 2.3% |
KR Fundamental Data Overview March 28, 2026
P/E Trailing = 46.6169
P/E Forward = 13.986
P/S = 0.2986
P/B = 7.5716
P/EG = 1.7263
Revenue TTM = 147.64b USD
EBIT TTM = 1.82b USD
EBITDA TTM = 5.47b USD
Long Term Debt = 14.55b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.44b USD (from shortTermDebt, last quarter)
Debt = 24.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.35b USD (from netDebt column, last quarter)
Enterprise Value = 64.18b USD (44.08b + Debt 24.68b - CCE 4.58b)
Interest Coverage Ratio = 2.59 (Ebit TTM 1.82b / Interest Expense TTM 704.0m)
EV/FCF = 18.19x (Enterprise Value 64.18b / FCF TTM 3.53b)
FCF Yield = 5.50% (FCF TTM 3.53b / Enterprise Value 64.18b)
FCF Margin = 2.39% (FCF TTM 3.53b / Revenue TTM 147.64b)
Net Margin = 0.69% (Net Income TTM 1.02b / Revenue TTM 147.64b)
Gross Margin = 22.28% ((Revenue TTM 147.64b - Cost of Revenue TTM 114.74b) / Revenue TTM)
Gross Margin QoQ = 21.31% (prev 21.03%)
Tobins Q-Ratio = 1.29 (Enterprise Value 64.18b / Total Assets 49.94b)
Interest Expense / Debt = 0.60% (Interest Expense 149.0m / Debt 24.68b)
Taxrate = 22.85% (255.0m / 1.12b)
NOPAT = 1.40b (EBIT 1.82b * (1 - 22.85%))
Current Ratio = 0.80 (Total Current Assets 14.51b / Total Current Liabilities 18.09b)
Debt / Equity = 4.16 (Debt 24.68b / totalStockholderEquity, last quarter 5.94b)
Debt / EBITDA = 3.90 (Net Debt 21.35b / EBITDA 5.47b)
Debt / FCF = 6.05 (Net Debt 21.35b / FCF TTM 3.53b)
Total Stockholder Equity = 7.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.98% (Net Income 1.02b / Total Assets 49.94b)
RoE = 13.04% (Net Income TTM 1.02b / Total Stockholder Equity 7.79b)
RoCE = 8.15% (EBIT 1.82b / Capital Employed (Equity 7.79b + L.T.Debt 14.55b))
RoIC = 5.76% (NOPAT 1.40b / Invested Capital 24.36b)
WACC = 3.47% (E(44.08b)/V(68.76b) * Re(5.15%) + D(24.68b)/V(68.76b) * Rd(0.60%) * (1-Tc(0.23)))
Discount Rate = 5.15% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -6.90%
[DCF] Terminal Value 86.63% ; FCFF base≈2.83b ; Y1≈2.92b ; Y5≈3.29b
[DCF] Fair Price = 123.8 (EV 97.36b - Net Debt 21.35b = Equity 76.02b / Shares 614.0m; r=6.0% [WACC]; 5y FCF grow 3.05% → 3.0% )
EPS Correlation: 13.47 | EPS CAGR: -3.27% | SUE: 1.20 | # QB: 2
Revenue Correlation: -20.38 | Revenue CAGR: -6.46% | SUE: -1.17 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.59 | Chg7d=+0.004 | Chg30d=-0.102 | Revisions Net=-12 | Analysts=20
EPS current Year (2027-01-31): EPS=5.25 | Chg7d=-0.007 | Chg30d=-0.050 | Revisions Net=-13 | Growth EPS=+8.2% | Growth Revenue=+1.4%
EPS next Year (2028-01-31): EPS=5.62 | Chg7d=-0.004 | Chg30d=+0.021 | Revisions Net=+0 | Growth EPS=+7.2% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: -0.86 (1 Up / 13 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.8% (Discount Rate 7.9% - Earnings Yield 2.1%)
[Growth] Growth Spread = -5.4% (Analyst 0.4% - Implied 5.8%)
P/E Forward = 13.986
P/S = 0.2986
P/B = 7.5716
P/EG = 1.7263
Revenue TTM = 147.64b USD
EBIT TTM = 1.82b USD
EBITDA TTM = 5.47b USD
Long Term Debt = 14.55b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.44b USD (from shortTermDebt, last quarter)
Debt = 24.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.35b USD (from netDebt column, last quarter)
Enterprise Value = 64.18b USD (44.08b + Debt 24.68b - CCE 4.58b)
Interest Coverage Ratio = 2.59 (Ebit TTM 1.82b / Interest Expense TTM 704.0m)
EV/FCF = 18.19x (Enterprise Value 64.18b / FCF TTM 3.53b)
FCF Yield = 5.50% (FCF TTM 3.53b / Enterprise Value 64.18b)
FCF Margin = 2.39% (FCF TTM 3.53b / Revenue TTM 147.64b)
Net Margin = 0.69% (Net Income TTM 1.02b / Revenue TTM 147.64b)
Gross Margin = 22.28% ((Revenue TTM 147.64b - Cost of Revenue TTM 114.74b) / Revenue TTM)
Gross Margin QoQ = 21.31% (prev 21.03%)
Tobins Q-Ratio = 1.29 (Enterprise Value 64.18b / Total Assets 49.94b)
Interest Expense / Debt = 0.60% (Interest Expense 149.0m / Debt 24.68b)
Taxrate = 22.85% (255.0m / 1.12b)
NOPAT = 1.40b (EBIT 1.82b * (1 - 22.85%))
Current Ratio = 0.80 (Total Current Assets 14.51b / Total Current Liabilities 18.09b)
Debt / Equity = 4.16 (Debt 24.68b / totalStockholderEquity, last quarter 5.94b)
Debt / EBITDA = 3.90 (Net Debt 21.35b / EBITDA 5.47b)
Debt / FCF = 6.05 (Net Debt 21.35b / FCF TTM 3.53b)
Total Stockholder Equity = 7.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.98% (Net Income 1.02b / Total Assets 49.94b)
RoE = 13.04% (Net Income TTM 1.02b / Total Stockholder Equity 7.79b)
RoCE = 8.15% (EBIT 1.82b / Capital Employed (Equity 7.79b + L.T.Debt 14.55b))
RoIC = 5.76% (NOPAT 1.40b / Invested Capital 24.36b)
WACC = 3.47% (E(44.08b)/V(68.76b) * Re(5.15%) + D(24.68b)/V(68.76b) * Rd(0.60%) * (1-Tc(0.23)))
Discount Rate = 5.15% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -6.90%
[DCF] Terminal Value 86.63% ; FCFF base≈2.83b ; Y1≈2.92b ; Y5≈3.29b
[DCF] Fair Price = 123.8 (EV 97.36b - Net Debt 21.35b = Equity 76.02b / Shares 614.0m; r=6.0% [WACC]; 5y FCF grow 3.05% → 3.0% )
EPS Correlation: 13.47 | EPS CAGR: -3.27% | SUE: 1.20 | # QB: 2
Revenue Correlation: -20.38 | Revenue CAGR: -6.46% | SUE: -1.17 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.59 | Chg7d=+0.004 | Chg30d=-0.102 | Revisions Net=-12 | Analysts=20
EPS current Year (2027-01-31): EPS=5.25 | Chg7d=-0.007 | Chg30d=-0.050 | Revisions Net=-13 | Growth EPS=+8.2% | Growth Revenue=+1.4%
EPS next Year (2028-01-31): EPS=5.62 | Chg7d=-0.004 | Chg30d=+0.021 | Revisions Net=+0 | Growth EPS=+7.2% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: -0.86 (1 Up / 13 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.8% (Discount Rate 7.9% - Earnings Yield 2.1%)
[Growth] Growth Spread = -5.4% (Analyst 0.4% - Implied 5.8%)